PHARMASGP HOLDING SE O.N. news, videos and press releases
For more news please use our advanced search feature.
PHARMASGP HOLDING SE O.N. - More news...
PHARMASGP HOLDING SE O.N. - More news...
- EQS-News: PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised
- EQS-News: CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025
- EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer
- EQS-News: PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer
- EQS-News: PharmaSGP continues dynamic growth path in the first half of 2024
- EQS-Adhoc: PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares
- EQS-News: PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
- EQS-News: PharmaSGP Holding SE strengthens the Management Board to further accelerate growth
- EQS-News: PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024
- EQS-Adhoc: PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
- EQS-News: PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
- EQS-News: PharmaSGP continues the profitable growth course of the previous quarters in the third quarter of 2023
- EQS-News: PharmaSGP achieves top performance in the first half of 2023
- EQS-News: PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
- EQS-News: PharmaSGP with a significant leap in revenue in Q1 2023 – EBITDA grows by more than 40%
- EQS-News: PharmaSGP plans dividend distribution of 49.2% after record year in 2022
- EQS-News: PharmaSGP confirms record revenue and record profitability for 2022 and publishes forecast for 2023
- EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
- EQS-News: PharmaSGP achieves new record revenue of more than € 85.5 million for 2022 exceeding analysts’ expectations
- EQS-Adhoc: PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro
- EQS-News: PharmaSGP posts record revenues (+39%) and record earnings (+54%) in 9M 2022 – raises full-year forecast
- EQS-Adhoc: PharmaSGP Holding SE raises forecast for FY 2022
- DGAP-News: PharmaSGP reports record revenues (+59%) and record earnings (+86%) in the first half of 2022
- DGAP-News: PharmaSGP successfully secures financing of up to € 160 million
- DGAP-News: PharmaSGP Holding SE successfully holds 2022 AGM
- DGAP-News: PharmaSGP: Another revenue record – Q1 2022 revenues up 67% year-on-year
- DGAP-News: PharmaSGP expects to see clear double-digit revenue and profit growth in 2022
- DGAP-News: PharmaSGP - Dividend at the upper end of the announced bandwidth after a record year in 2021
- DGAP-News: PharmaSGP achieves record results in 2021 - Adjusted EBITDA in Q4 up fivefold year-on-year
- DGAP-News: PharmaSGP achieves record revenues in 2021 and exceeds analysts' expectations
